EFFICACY AND SAFETY OF SUBCUTANEOUS VERSUS INTRAVENOUS TOCILIZUMAB IN COMBINATION WITH TRADITIONAL DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS: 49 WEEK SUMMACTA DATA

被引：0
|
作者：
Burmester, Gerd R. [1 ,2 ,3 ]
Rubbert-Roth, Andrea [4 ]
Cantagrel, Alain [5 ]
Hall, Stephen [6 ]
Leszczynski, Piotr [7 ]
Feldman, Daniel [8 ]
Rangaraj, Madura J. [9 ]
Roane, Georgia [10 ]
Ludivico, Charles [11 ]
Mysler, Eduardo F. [12 ]
Wells, Chris [13 ]
Bennett, Melanie [13 ]
Vranic, Ivana [13 ]
机构：
[1] Charite, D-13353 Berlin, Germany
[2] Free Univ Berlin, Berlin, Germany
[3] Humboldt Univ, D-10099 Berlin, Germany
[4] Klinikum Univ Koln, Dept Internal Med, Cologne, Germany
[5] Ctr Hosp Univ Toulouse, Dept Rheumatol, Toulouse, France
[6] Cabrini Med Ctr, Dept Rheumatol, Malvern, Australia
[7] Poznan Univ Med Sci, Dept Physiotherapy Rheumatol & Rehabil, Poznan, Poland
[8] Univ Fed Sao Paulo, Dept Rheumatol, Sao Paulo, Brazil
[9] Arthrit & Diabet Clin Inc, Arthrit & Diabet Clin, Monroe, LA USA
[10] Rheumatol Associates, Dept Rheumatol, Charleston, SC USA
[11] East Penn Rheumatol Associates, Dept Rheumatol, Bethlehem, PA USA
[12] Org Med Invest, Dept Rheumatol, Buenos Aires, DF, Argentina
[13] Roche Prod Ltd, Dept Med, Garden City, Herts, England
来源：
RHEUMATOLOGY | 2014年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O22
引用
收藏
页码：37 / 38
页数：2
相关论文
共 50 条
  • [41] SAFETY AND EFFICACY OF SUBCUTANEOUS TOCILIZUMAB IN PATIENTS WITH SYSTEMIC AND POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
    Ramanan, Athimalaipet V.
    Brunner, Hermine I.
    Ruperto, Nicola
    Martini, Alberto
    Cuttica, Ruben J.
    Weiss, Jennifer E.
    Henrickson, Michael
    Schmeling, Heinrike
    Anton, Jordi
    Minden, Kirsten
    Horneff, Gerd
    Gamir-Gamir, Maria Luz
    Hufnagel, Markus
    Douglass, Wendy
    Wells, Chris
    Wimalasundera, Sunethra
    Mallalieu, Navita L.
    Lovell, Daniel J.
    De Benedetti, Fabrizio
    RHEUMATOLOGY, 2019, 58
  • [42] Which Factors Influence the Prescription of Tocilizumab Alone or in Combination with DMARDs in Rheumatoid Arthritis Patients in a Real Life Setting? An Interim Analysis of Safety and Efficacy at 6 Months.
    Tebib, Jacques
    Idier, Isabelle
    Coudert, Mathieu
    Pau, David
    Flipo, Rene-Marc
    Maillefert, Jean-Francis
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1082 - S1082
  • [43] COST-EFFICACY ANALYSIS OF BIOLOGIC DRUGS IN COMBINATION WITH DMARDS IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO TRADITIONAL DMARDS IN PORTUGAL - A SIMPLIFIED APPROACH
    Cafe, A.
    Monteiro, I
    Loff, J. F.
    Encarnacao, R.
    VALUE IN HEALTH, 2012, 15 (07) : A445 - A445
  • [44] Efficacy and safety of baricitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic DMARDs and/or biological DMARDs: Data from a local registry
    Rosas, Jose
    Senabre-Gallego, Jose Miguel
    Santos-Soler, Gregorio
    Bernal, Jose Antonio
    Bas, Ana Pons
    REUMATOLOGIA CLINICA, 2022, 18 (03): : 188 - 189
  • [45] Safety and Efficacy Of Subcutaneous Tocilizumab Monotherapy In a Long-Term Extension Study In Japanese Rheumatoid Arthritis Patients.
    Ogata, Atsushi
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S605 - S606
  • [46] Safety and efficacy of Tocilizumab as monotherapy or in combination with MTX in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: Subanalysis of the Austrian and Swiss patients of the ACT-SURE study
    Ruediger, Mueller
    Winfried, Graninger
    Paris, Sidiropoulos
    Christoph, Goger
    Johannes, von Kempis
    SWISS MEDICAL WEEKLY, 2016, 146 : 8S - 8S
  • [47] Retreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study
    Nishimoto, Norihiro
    Amano, Koichi
    Hirabayashi, Yasuhiko
    Horiuchi, Takahiko
    Ishii, Tomonori
    Iwahashi, Mitsuhiro
    Iwamoto, Masahiro
    Kohsaka, Hitoshi
    Kondo, Masakazu
    Matsubara, Tsukasa
    Mimura, Toshihide
    Miyahara, Hisaaki
    Ohta, Shuji
    Saeki, Yukihiko
    Saito, Kazuyoshi
    Sano, Hajime
    Takasugi, Kiyoshi
    Takeuchi, Tsutomu
    Tohma, Shigeto
    Tsuru, Tomomi
    Ueki, Yukitaka
    Yamana, Jiro
    Hashimoto, Jun
    Matsutani, Takaji
    Murakami, Miho
    Takagi, Nobuhiro
    MODERN RHEUMATOLOGY, 2014, 24 (01) : 26 - 32
  • [48] Clinical efficacy and safety of tocilizumab in the treatment of seropositive rheumatoid arthritis patients in India
    Kumar, Abhishek
    Bhakuni, Darshan
    Shanmuganandan, K.
    Hegde, Arun
    Vasdev, Vivek
    Arjun, M. N.
    Kishore, Kunal
    INDIAN JOURNAL OF RHEUMATOLOGY, 2020, 15 (04) : 286 - 291
  • [49] TOCILIZUMAB: ANALYSIS OF LONG-TERM EFFICACY AND SAFETY IN RHEUMATOID ARTHRITIS PATIENTS
    Chalmeta Verdejo, I.
    Gonzalez Puig, L.
    Labrador Sanchez, E.
    Feced Olmos, C. M.
    Grau Garcia, E.
    Ivorra Cortes, J.
    Martinez Cordellat, I.
    Negueroles Albuixech, R.
    Nunez-Cornejo Piquer, C.
    Ortiz Sanjuan, F. M.
    Valero Sanz, J. L.
    Arevalo Ruales, K.
    Alcaniz Escandell, C.
    Roman Ivorra, J. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1049 - 1049
  • [50] THE EFFICACY AND SAFETY OF TOFACITINIB IN THE TREATMENT OF DMARDS NAIVE RHEUMATOID ARTHRITIS PATIENTS (EASTERN STUDY)
    Zhao, J.
    Wang, Y.
    Zhang, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1441 - 1441
12345